{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T01:10:14Z","timestamp":1777597814777,"version":"3.51.4"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,4,17]],"date-time":"2019-04-17T00:00:00Z","timestamp":1555459200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1007\/s00520-019-04793-2","type":"journal-article","created":{"date-parts":[[2019,4,18]],"date-time":"2019-04-18T09:27:51Z","timestamp":1555579671000},"page":"177-184","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The use of crevicular fluid to assess markers of inflammation and angiogenesis, IL-17 and VEGF, in patients with solid tumors receiving zoledronic acid and\/or bevacizumab"],"prefix":"10.1007","volume":"28","author":[{"given":"Erofili","family":"Papadopoulou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ourania","family":"Nicolatou-Galitis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ioannis","family":"Papassotiriou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helena","family":"Linardou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aikaterini","family":"Karagianni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantinos","family":"Tsixlakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthi","family":"Tarampikou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelly","family":"Michalakakou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanouil","family":"Vardas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitrios","family":"Bafaloukos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,4,17]]},"reference":[{"key":"4793_CR1","doi-asserted-by":"publisher","first-page":"623759","DOI":"10.1155\/2014\/623759","volume":"2014","author":"B Yang","year":"2014","unstructured":"Yang B, Hang H, Fung A, Zhao H et al (2014) The role of interleukin 17 in tumour proliferation, angiogenesis and metastasis. Mediat Inflamm 2014:623759. \nhttps:\/\/doi.org\/10.1155\/2014\/623759","journal-title":"Mediat Inflamm"},{"key":"4793_CR2","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1111\/jcpe.12238","volume":"41","author":"WC Cheng","year":"2014","unstructured":"Cheng WC, Hughes FJ, Taams LS (2014) The presence, function and regulation of IL-17 and Th17 cells in periodontitis. J Clin Periodontol 41:541\u2013549. \nhttps:\/\/doi.org\/10.1111\/jcpe.12238","journal-title":"J Clin Periodontol"},{"issue":"203","key":"4793_CR3","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.1084\/jem.20061775","volume":"27","author":"K Sato","year":"2006","unstructured":"Sato K, Suematsu A, Okamoto K, Yamaguchi A, Morishita Y, Kadono Y, Tanaka S, Kodama T, Akira S, Iwakura Y, Cua DJ, Takayanagi H (2006) Th17 functions as an osteoclastogenic helper T cell subject that links T cell activation and bone destruction. J Exp Med 27(203):2673\u20132682. \nhttps:\/\/doi.org\/10.1084\/jem.20061775","journal-title":"J Exp Med"},{"key":"4793_CR4","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1002\/art.21749","volume":"54","author":"BW Kirkham","year":"2006","unstructured":"Kirkham BW, Lassere MN, Edmonds JP, Juhasz KM, Bird BA, Lee CS, Shnier R, Portek IJ (2006) Synovial membrane cytokine expression is predictive of joint damage progression in rheumatoid arthritis: a two-year prospective study (the DAMAGE study cohort). Arthritis Rheum 54:1122\u20131131. \nhttps:\/\/doi.org\/10.1002\/art.21749","journal-title":"Arthritis Rheum"},{"key":"4793_CR5","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.pbiomolbio.2013.10.001","volume":"113","author":"RN Gacche","year":"2013","unstructured":"Gacche RN, Meshram RJ (2013) Targeting tumor micro-environment for design and development of novel anti-angiogenic agents arresting tumor growth. Prog Biophys Mol Biol 113:333\u2013354. \nhttps:\/\/doi.org\/10.1016\/j.pbiomolbio.2013.10.001","journal-title":"Prog Biophys Mol Biol"},{"key":"4793_CR6","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/S0361-090X(03)00030-8","volume":"27","author":"D Bissachi","year":"2003","unstructured":"Bissachi D, Benelli R, Vanzetto C et al (2003) Anti-angiogenesis and angioprevention: mechanisms, problems and perspectives. Cancer Detect Prev 27:229\u2013238","journal-title":"Cancer Detect Prev"},{"key":"4793_CR7","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.oooo.2015.08.007","volume":"120","author":"O Nicolatou-Galitis","year":"2015","unstructured":"Nicolatou-Galitis O, Razis E, Galiti D, Galitis E, Labropoulos S, Tsimpidakis A, Sgouros J, Karampeazis A, Migliorati C (2015) Periodontal disease preceding osteonecrosis of the jaw (ONJ) in cancer patients receiving aniresorptives alone or combined with targeted therapies: report of 5 cases and literature review. Oral Surg Oral Med Oral Pathol Oral Radiol 120:699\u2013706. \nhttps:\/\/doi.org\/10.1016\/j.oooo.2015.08.007","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"4793_CR8","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1016\/j.joms.2013.02.016","volume":"71","author":"C Tsao","year":"2013","unstructured":"Tsao C, Darby I, Ebeling P, Walsh K et al (2013) Oral health risk factors for bisphosphonate-associated jaw osteonecrosis. J Oral Maxillofac Surg 71:1360\u20131366. \nhttps:\/\/doi.org\/10.1016\/j.joms.2013.02.016","journal-title":"J Oral Maxillofac Surg"},{"key":"4793_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/1756-8722-5-56","volume":"5","author":"B Vincenzi","year":"2012","unstructured":"Vincenzi B, Napolitano A, Zoccoli A, Iuliani M, Pantano F, Papapietro N, Denaro V, Santini D, Tonini G (2012) Serum VEGF levels as predictive marker of bisphosphonate-related osteonecrosis of the jaw. J Hematol Oncol 5:56. \nhttps:\/\/doi.org\/10.1186\/1756-8722-5-56","journal-title":"J Hematol Oncol"},{"key":"4793_CR10","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/BF02867658","volume":"18","author":"MV Subrahmanyaam","year":"2003","unstructured":"Subrahmanyaam MV, Sangyeetha M (2003) Gingival crevicular fluid a marker of the periodontal disease activity. Indian J Clin Biochem 18:5\u20137. \nhttps:\/\/doi.org\/10.1007\/BF02867658","journal-title":"Indian J Clin Biochem"},{"key":"4793_CR11","doi-asserted-by":"publisher","first-page":"449","DOI":"10.4103\/1735-3327.166193","volume":"12","author":"PL Longo","year":"2015","unstructured":"Longo PL, Artese HPC, Horliana ACRT, Gomes GH, Ramito GA et al (2015) Inflammatory markers in gingival crevicular fluid of periodontitis patients with type 2 diabetes mellitus according to glycerine control: a pilot study. Dent Res J (Isfahan) 12:449\u2013455","journal-title":"Dent Res J (Isfahan)"},{"key":"4793_CR12","doi-asserted-by":"publisher","first-page":"3554","DOI":"10.1182\/blood-2010-05-283895","volume":"116","author":"K Noonan","year":"2010","unstructured":"Noonan K, Marchionni L, Anderson J, Pardoll D, Roodman GD, Borrello I (2010) A novel role of IL-17-producing lymphocytes in mediating lytic bone disease in multiple myeloma. Blood 116:3554\u20133563. \nhttps:\/\/doi.org\/10.1182\/blood-2010-05-283895","journal-title":"Blood"},{"key":"4793_CR13","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1007\/s10753-014-0060-6","volume":"38","author":"Z Luo","year":"2015","unstructured":"Luo Z, Wang H, Chen J, Kang J, Sun Z, Wu Y (2015) Overexpression and potential regulatory role of IL-17F in pathogenesis of chronic periodontitis. Inflammation 38:978\u2013986. \nhttps:\/\/doi.org\/10.1007\/s10753-014-0060-6","journal-title":"Inflammation"},{"key":"4793_CR14","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1111\/prd.12083.","volume":"69","author":"C Zenobia","year":"2015","unstructured":"Zenobia C, Hajishengallis G (2015) Basic biology and role of interleukin-17 in immunity and inflammation. Periodontol 69:142\u2013159. \nhttps:\/\/doi.org\/10.1111\/prd.12083.","journal-title":"Periodontol"},{"key":"4793_CR15","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1016\/j.joen.2014.03.024","volume":"40","author":"N Ajuz","year":"2014","unstructured":"Ajuz N, Antunes H, Mendonca T, Pires F et al (2014) Immunosuppression of interleukin-17 in apical periodontitis lesions. JOE 40:1400\u20131403. \nhttps:\/\/doi.org\/10.1016\/j.joen.2014.03.024","journal-title":"JOE"},{"key":"4793_CR16","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1002\/jbmr.37","volume":"25","author":"T Kikuiri","year":"2010","unstructured":"Kikuiri T, Kim I, Yamaza T, Akiyama K, Zhang Q, Li Y, Chen C, Chen WJ, Wang S, le AD, Shi S (2010) Cell-based immunotherapy with mesenchymal stem cells cures bisphosphonate-related osteonecrosis of the jaw-like disease in mice. J Bone Miner Res 25:1668\u20131679. \nhttps:\/\/doi.org\/10.1002\/jbmr.37","journal-title":"J Bone Miner Res"},{"key":"4793_CR17","doi-asserted-by":"publisher","first-page":"3176","DOI":"10.1158\/1078-0432.CCR-13-0042","volume":"19","author":"Q Zhang","year":"2013","unstructured":"Zhang Q, Atsuta I, Liu S, Chen C, Shi S, Shi S, le AD (2013) IL-17-mediated M1\/M2 macrophage alteration contributes to pathogenesis of bisphosphonate-related osteonecrosis of the jaws. Clin Cancer Res 19:3176\u20133188. \nhttps:\/\/doi.org\/10.1158\/1078-0432.CCR-13-0042","journal-title":"Clin Cancer Res"},{"key":"4793_CR18","doi-asserted-by":"publisher","first-page":"97","DOI":"10.4103\/2231-0762.178742","volume":"6","author":"D Rosella","year":"2016","unstructured":"Rosella D, Papi P, Giardino R, Cicalini E, Piccoli L, Pompa G (2016) Medication-related osteonecrosis of the jaw: clinical and practical guidelines. J Int Soc Prev Community Dent 6:97\u2013104. \nhttps:\/\/doi.org\/10.4103\/2231-0762.178742","journal-title":"J Int Soc Prev Community Dent"},{"key":"4793_CR19","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.tripleo.2011.02.037","volume":"112","author":"O Nicolatou-Galitis","year":"2011","unstructured":"Nicolatou-Galitis O, Papadopoulou E, Sarri T, Boziari P, Karayianni A, Kyrtsonis MC, Repousis P, Barbounis V, Migliorati CA (2011) Osteonecrosis of the jaw in oncology patients treated with bisphosphonates: prospective experience of a dental oncology referral center. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 112:195\u2013202. \nhttps:\/\/doi.org\/10.1016\/j.tripleo.2011.02.037","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"4793_CR20","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1093\/annonc\/mdn554","volume":"20","author":"MA Dimopoulos","year":"2009","unstructured":"Dimopoulos MA, Kastritis E, Bamia C, Melakopoulos I, Gika D, Roussou M, Migkou M, Eleftherakis-Papaiakovou E, Christoulas D, Terpos E, Bamias A (2009) Reduction of osteonecrosis of the jaw (ONJ) after implementation of preventive measures in patients with multiple myeloma treated with zoledronic acid. Ann Oncol 20:117\u2013120. \nhttps:\/\/doi.org\/10.1093\/annonc\/mdn554","journal-title":"Ann Oncol"},{"key":"4793_CR21","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1093\/annonc\/mdn526","volume":"20","author":"CI Ripamonti","year":"2009","unstructured":"Ripamonti CI, Maniezzo M, Campa T, Fagnoni E, Brunelli C, Saibene G, Bareggi C, Ascani L, Cislaghi E (2009) Decreased occurrence of osteonecrosis of the jaw after implementation of dental preventive measures in solid tumour patients with bone metastases treated with bisphosphonates. The experience of the National Cancer Institute of Milan. Ann Oncol 20:137\u2013145. \nhttps:\/\/doi.org\/10.1093\/annonc\/mdn526","journal-title":"Ann Oncol"},{"key":"4793_CR22","first-page":"53","volume":"30","author":"M Vladau","year":"2016","unstructured":"Vladau M, Cimpean AM, Balica RA, Jitariu AA, Popovici RA, Raica M (2016) VEGF\/VEGFR2 Axis in periodontal disease progression and angiogenesis: basic approach for a new therapeutic strategy. In Vivo 30:53\u201360","journal-title":"In Vivo"},{"key":"4793_CR23","first-page":"75","volume":"8","author":"R Padma","year":"2014","unstructured":"Padma R, Anaji S, Indeevar P, Indranil S, Chetan SK (2014) Vascular endothelial growth factor levels in gingival crevicular fluid before and after periodontal therapy. J Clin Diagn Res 8:75\u201379","journal-title":"J Clin Diagn Res"},{"key":"4793_CR24","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1902\/jop.2007.070009","volume":"78","author":"DV Prapulla","year":"2007","unstructured":"Prapulla DV, Sujatha PB, Pradeep AR (2007) Gingival crevicular fluid VEGF levels in periodontal health and disease. J Periodontol 78:1783\u20131787. \nhttps:\/\/doi.org\/10.1902\/jop.2007.070009","journal-title":"J Periodontol"},{"issue":"suppl","key":"4793_CR25","first-page":"152","volume":"25","author":"D Santini","year":"2007","unstructured":"Santini D, Vincenzi B, Battistoni F et al (2007) In vivo perspective study about the effects of weekly low dose administration of zoledronic acid (ZA) on angiogenesis. J Clin Oncol 25(suppl):152","journal-title":"J Clin Oncol"},{"key":"4793_CR26","first-page":"2893","volume":"9","author":"D Santini","year":"2003","unstructured":"Santini D, Vincenzi B, Dicuonzo G, Avvisati G, Massacesi C, Battistoni F, Gavasci M, Rocci L, Tirindelli MC, Altomare V, Tocchini M, Bonsignori M, Tonini G (2003) ZA induces significant and long-lasting modifications of circulating angiogenic factors in cancer patients. Clin Cancer Res 9:2893\u20132897","journal-title":"Clin Cancer Res"},{"key":"4793_CR27","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1007\/s12032-008-9043-5","volume":"25","author":"F Tas","year":"2008","unstructured":"Tas F, Duranyildiz D, Oguz H, Camlica H, Yasasever V, Topuz E (2008) Effect of zoledronic acid on serum angiogenic factors in patients with bone metastases. Med Oncol 25:346\u2013349. \nhttps:\/\/doi.org\/10.1007\/s12032-008-9043-5","journal-title":"Med Oncol"},{"issue":"4","key":"4793_CR28","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/j.joms.2015.09.028","volume":"74","author":"V Thumbigere-Math","year":"2016","unstructured":"Thumbigere-Math V, Michalowicz B, Hughes PJ, Basi DL et al (2016) Serum markers of bone turnover and angiogenesis in bisphosphonate-related osteonecrosis of the jaw patients following discontinuation of long-term intravenous bisphosphonate therapy. J Oral Maxillofac Surg 74(4):738\u2013746. \nhttps:\/\/doi.org\/10.1016\/j.joms.2015.09.028","journal-title":"J Oral Maxillofac Surg"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-019-04793-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00520-019-04793-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-019-04793-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,15]],"date-time":"2020-04-15T23:14:28Z","timestamp":1586992468000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00520-019-04793-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,17]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["4793"],"URL":"https:\/\/doi.org\/10.1007\/s00520-019-04793-2","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,17]]},"assertion":[{"value":"29 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"They were all informed about the study and signed a detailed informed consent form. Ethical approval for the study was obtained by the Committee of Research and Ethics of the Dental School, National and Kapodistrian University of Athens.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}